E-mail:

Name:

Country:

Profession:


Get this Wordpress newsletter widget
for newsletter software
RSNA 2011
Radiology Teaching Files - MRI, Ultrasound Technologist Training

 

March 2010
M T W T F S S
« Feb   Apr »
1234567
891011121314
15161718192021
22232425262728
293031  
Media Partnership

Archives

Telemed Providers
Doctors 2.0 & You 2012 Event in Paris
Industry Leaders to Join 3rd OHS Forum in Kuwait
2nd Iraq Health Expo 2012 International Medical Equipment, Healthcare Industry and Services Exhibit

Teva to Launch A Drug for Treating Lupus

Teva Industries is investigating whether its drug Laquinimod, which is in Phase III clinical trial for treating Multiple Sclerosis, is suitable for treating lupus.

Teva will soon begin recruiting patients for a Phase IIa clinical trial for Laquinimod for treating lupus nephritis, which affects the kidneys, and lupus arthritis, which affects joints. The trial is slated to begin in the summer.

The US Food and Drug Administration () is investigating the drug for fast track approval, and could be approved for marketing by 2012. The approval will only be for Multiple Sclerosis but there are indications that Laquinimod is effective for treating other autoimmune diseases such as Crohn’s disease, arthritis and arthritis as well as Lupus.

VN:F [1.9.17_1161]
Rating: 0.0/10 (0 votes cast)
VN:F [1.9.17_1161]
Rating: +1 (from 1 vote)

Leave a Reply

 

 

 

You can use these HTML tags

<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

*